OakChart

Insmed Inc

INSMHealthcare·Biotechnology·USA·Large·NASD·Nov 11 • 2:13 PM ET

119.69+0.21 (0.17%)
2026-11-11 20:14 CET
Market cap
26,213.72 USD m
Revenue, TTM
1,519.72 USD m
Net income, TTM
-605.61 USD m
Free cash flow, TTM
-657.58 USD m
EPS diluted, TTM
-2.82
P/E
-
Compare

Price

INSM against its 20, 50 and 200-day averages
2050200beatmiss
100.00120.00140.0011.7M23.4MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26INSMclose 119.7020-day 104.0350-day 111.08200-day 123.53119.7052w low

43.7% under the 52-week high of 212.75 on 2 Dec 2025. 52-week low 90.39 on 10 Jun 2026. Last 15 sessions, 29.5% high to low

Profile

INSM
52-week range, 24% of the way up
90.39212.75

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.

IndexRUI
Employees1664
IPOFeb 15, 1991
Beta0.80
ATR, 14d4.92
Rel volume0.30
Short float6.51%
Insider own1.48%
Inst own103.61%

Snapshot

6 groups

Valuation

IndexRUI
Market Cap26.26B
Enterprise Value25.86B
Income-605.61M
Sales1.52B
Book/sh3.31
Cash/sh5.23
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees1664
IPOFeb 15, 1991

Ratios

P/E-
Forward P/E172.18
PEG-
P/S17.28
P/B36.15
P/C22.90
P/FCF-
EV/EBITDA-
EV/Sales17.02
Quick Ratio2.59
Current Ratio2.86
Debt/Eq1.03
LT Debt/Eq0.99
Option/ShortYes / Yes

Earnings

EPS (ttm)-2.82
EPS next Y0.70
EPS next Q-0.31
EPS this Y74.39%
EPS next Y142.27%
EPS next 5Y-
EPS past 3/5Y-17.91% -16.32%
Sales past 3/5Y35.20% 29.83%
EPS Y/Y TTM54.44%
Sales Y/Y TTM239.97%
EPS Q/Q73.76%
Sales Q/Q268.43%
EarningsOct 29 BMO
EPS/Sales Surpr.-20.20% 4.81%

Ownership

Insider Own1.48%
Insider Trans-12.74%
Inst Own103.61%
Inst Trans5.57%
ROA-26.41%
ROE-72.45%
ROIC-41.90%
Gross Margin83.67%
Oper. Margin-41.66%
Profit Margin-39.85%
SMA2015.06%
SMA507.75%
SMA200-3.10%
Trades-

Technical

Shs Outstand219.32M
Shs Float216.13M
Short Float6.51%
Short Ratio5.05
Short Interest14.08M
52W High212.75 -43.74%
52W Low90.39 32.42%
Volatility5.40% 4.15%
ATR (14)4.92
RSI (14)65.65
Beta0.80
Rel Volume0.30
Avg Volume2.79M
Volume624,999

Performance

Perf Week8.81%
Perf Month23.66%
Perf Quarter-5.25%
Perf Half Y1.45%
Perf YTD-31.23%
Perf Year-38.20%
Perf 3Y403.98%
Perf 5Y276.28%
Perf 10Y728.34%
Recom1.20
Target Price194.18
Prev Close119.49
Price119.69
Change %0.17%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Nov 04, 2026ResumedHH.C. WainwrightBuy$220+83.8%
Oct 12, 2026DowngradeWWolfe ResearchOutperform → Peer Perform
Sep 24, 2026ResumedGGoldmanBuy$188+57.1%
Jul 21, 2026InitiatedBBMO Capital MarketsOutperform$192+60.4%
Apr 10, 2026InitiatedRRaymond JamesOutperform$200+67.1%
Mar 30, 2026UpgradeMMorgan StanleyEqual-Weight → Overweight$212+77.1%
Mar 16, 2026ResumedJJefferiesBuy
Jan 28, 2026InitiatedBBarclaysOverweight$231+93.0%
Jan 23, 2026InitiatedRRoth CapitalBuy$212+77.1%
Dec 19, 2025ResumedTTruistBuy$202+68.8%

Peers

Mkt cap
TickerCompanyMkt cap
UTHRUnited Therapeutics Corp25.41B
VRTXVertex Pharmaceuticals Inc137.74B
ALNYAlnylam Pharmaceuticals Inc21.07B
ARGXArgen X SE ADR61.18B
ASNDAscendis Pharma A/S16.87B
BBIOBridgeBio Pharma Inc15.41B
MDGLMadrigal Pharmaceuticals Inc10.06B
LQDALiquidia Corp4.89B
SVRASavara Inc1.13B
REGNRegeneron Pharmaceuticals Inc98.03B

Insider trading

latest 14 of 100
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Sara BonsteinFormer OfficerNov 03 '26Proposed Sale109.3110,2611,121,629Nov 03 04:34 PM
Brennan David RDirectorSep 09 '26Sale124.0025,0003,100,00039,238Sep 11 04:04 PM
Brennan David RDirectorSep 09 '26Proposed Sale123.9925,0003,099,729Sep 10 10:22 AM
SHAROKY MELVIN MDDirectorAug 17 '26Sale127.535,000637,6500Aug 19 04:10 PM
MELVIN SHAROKYDirectorAug 17 '26Proposed Sale127.535,000637,637Aug 17 04:18 PM
Adsett RogerChief Operating OfficerAug 10 '26Option Exercise20.45239,8504,905,570338,594Aug 12 05:04 PM
Adsett RogerChief Operating OfficerAug 10 '26Sale133.27239,85031,964,81098,744Aug 12 05:04 PM
Roger AdsettOfficerAug 10 '26Proposed Sale133.26239,85031,963,198Aug 10 05:42 PM
Flammer Martina M.D.Chief Medical OfficerAug 06 '26Option Exercise21.2027,173576,12687,659Aug 07 04:39 PM
Flammer Martina M.D.Chief Medical OfficerAug 06 '26Sale128.6127,1733,494,83860,486Aug 07 04:39 PM
Martina FlammerOfficerAug 06 '26Proposed Sale128.6127,1733,494,755Aug 06 04:09 PM
Lewis WilliamChair and CEOJul 23 '26Option Exercise24.9410,700266,870269,758Jul 24 05:02 PM
Lewis WilliamChair and CEOJul 23 '26Sale106.0610,7001,134,890259,058Jul 24 05:02 PM
William LewisOfficerJul 23 '26Proposed Sale106.0610,7001,134,867Jul 23 04:38 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
VOVanguard Morningstar Mid-Cap ETFAUM: 107.07B
VUGVanguard Morningstar Growth ETFAUM: 217.67B
IBBiShares Biotechnology ETFAUM: 11.36B
VBKVanguard Morningstar Small-Cap Growth ETFAUM: 22.34B
IWPiShares Russell Mid-Cap Growth ETFAUM: 18.09B
XBIState Street SPDR S&P Biotech ETFAUM: 10.50B
IWRiShares Russell Mid-Cap ETFAUM: 58.68B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-29-0.460-0.383-0.460524.43500.3623
2026Q22026-08-06-0.060-0.672-0.061425.49395.518
2026Q12026-05-07-0.760-0.963-0.759305.96300.8119
2025Q42026-02-19-1.540-1.071-1.538263.84231.2517
2025Q32025-10-30-1.750-1.329-1.747142.34115.4517
2025Q22025-08-07-1.700-1.299-1.699107.42104.1317
2025Q12025-05-08-1.420-1.339-1.41992.8291.4716
2024Q42025-02-20-1.320-1.171-1.316104.44102.0816
2024Q32024-10-31-1.270-1.202-1.26993.4393.3617
2024Q22024-08-08-1.940-1.244-1.94390.3487.9516
2024Q12024-05-09-1.060-1.238-1.05875.5077.7617
2023Q42024-02-22-1.280-1.153-1.28583.6981.8815
2023Q32023-10-26-1.110-1.141-1.11279.0779.1412
2023Q22023-08-03-1.780-1.134-1.78077.2370.2312
2023Q12023-05-04-1.170-1.128-1.17265.2164.2513
2022Q42023-02-23-1.210-1.047-1.20759.3062.0913

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-3.010-2.958-3.008136.47135.84
2020FY-3.010-2.604-3.013164.41164.47
2021FY-3.880-3.819-3.877188.46179.85
2022FY-3.910-3.716-3.914245.36247.85
2023FY-5.340-5.212-5.338305.21303.42
2024FY-5.570-5.364-5.570363.71362.46
2025FY-6.420-5.854-6.420606.42582.38
2026FY--1.644--1,857
2027FY-0.695--2,991
2028FY-3.231--3,990
2029FY-6.479--5,033
2030FY-10.003--6,244

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0320191601.72560.09647.66
2026Q4S2026-10-3020191600.38560.09647.66
2026Q4S2026-10-2920172597.35558.1647.66
2026Q4S2026-10-282056576.02554625.83
2026Q4S2026-10-272056576.02554625.83
2026Q4S2026-10-202046573.85551625.83
2026Q4S2026-10-1920126573.85551625.83
2026Q4S2026-10-1420117566.85472625.83
2026Q4S2026-10-1320117566.83472625.83
2026Q4S2026-10-1220127566.83472625.83
2026Q4S2026-10-0920127566.22472636.31
2026Q4S2026-10-0720136566.19472636.31
2026Q4S2026-10-0620136566.27472636.31
2026Q4S2026-09-2920154571.03472636.31

Estimate history

EPS, annual-2.89-4.218-3.008-3.013-3.877-3.914-5.338-5.57-6.416-2.8161
Period201720182019202020212022202320242025TTM
EPS, quarterly-1.269-1.316-1.419-1.699-1.747-1.538-0.759-0.061-0.459
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual09.835136.467164.413188.461245.358305.208363.707606.4231519.72
Period201720182019202020212022202320242025TTM
Sales, quarterly93.425104.44292.823107.415142.342263.843305.964425.486524.428
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual76.61177.30889.682102.763118.738135.654147.978179.383214.256219.32
Period201720182019202020212022202320242025MRQ
Shares, quarterly178.847179.383181.9211.111212.583214.256216.522218.281219.32
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue1,519.72606.42363.71305.21245.36188.46164.41136.479.84
Cost of Goods Sold Incl. D&A248.22128.9490.7970.6260.1849.2044.8829.207.25
Gross Profit1,271.51477.48272.91234.58185.18139.26119.54107.262.59
Selling, General and Administrative Excl. Other1,904.631,472.261,059.48915.51663.30506.42384.77342.51309.92
Research and Development944.39771.09598.37571.01397.52272.74181.16131.71145.28
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-633.13-994.78-786.57-680.93-478.12-367.16-265.23-235.25-307.34
Interest Expense81.3683.8084.9181.6926.4540.4729.5627.7025.47
Unusual Expense-69.14251.9991.9228.38-19.2825.620.000.002.21
Net Income Before Taxes-598.06-1,271.75-910.07-747.01-480.15-436.41-292.69-253.56-324.08
Income Taxes7.555.033.712.561.38-1.761.400.780.20
Consolidated Net Income-605.61-1,276.78-913.77-749.57-481.53-434.65-294.09-254.34-324.28
Net Income From Continuing Operations-605.61-1,276.78-913.77-749.57-481.53-434.65-294.09-254.34-324.28
Net Income-605.61-1,276.78-913.77-749.57-481.53-434.65-294.09-254.34-324.28
EPS (Recurring)-2.99-5.53-5.18-5.20-4.02-3.72-3.01-3.01-4.20
EPS (Basic, Before Extraordinaries)-2.82-6.42-5.57-5.34-3.91-3.88-3.01-3.01-4.22
EPS (Diluted)-2.82-6.42-5.57-5.34-3.91-3.88-3.01-3.01-4.22
EBITDA-606.86-978.33-775.56-670.35-453.86-339.31-245.15-225.06-302.51
Non-Operating Income (Expense)47.2958.8153.3443.995.14-3.162.119.3910.94
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense132.14120.6476.5059.0745.5733.5926.4019.6920.70
Price To Sales Ratio16.4357.1231.1414.2610.0216.2019.7614.80102.57
Gross Margin83.6778.7475.0476.8675.4773.8972.7178.6026.29
Operating Margin-41.66-164.04-216.26-223.10-194.87-194.82-161.32-172.38-3,124.94
Net Margin-39.85-210.54-251.24-245.59-196.26-230.63-178.87-186.37-3,297.17
Shares Outstanding219.32214.26179.38147.98135.65118.74102.7689.6877.31
Market Capitalization26,213.7226,213.7249,405.8517,733.9710,827.3212,897.8113,564.748,534.144,045.68

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue524.43425.49305.96263.84142.34107.4292.82104.44
Cost of Goods Sold Incl. D&A83.2769.2949.5046.1630.9029.3422.5427.41
Gross Profit441.16356.19256.46217.69111.4478.0870.2877.03
Selling, General and Administrative Excl. Other522.99457.50456.74467.39372.79331.95300.12322.24
Research and Development269.96210.03209.49254.91186.41177.19152.58179.73
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-81.83-101.31-200.28-249.71-261.35-253.88-229.84-245.21
Interest Expense20.4120.2720.0820.6020.3821.2521.5721.55
Unusual Expense7.54-99.76-46.9670.04104.6559.0018.30-15.67
Net Income Before Taxes-97.65-11.37-162.10-326.93-368.70-320.44-255.67-234.28
Income Taxes2.671.871.471.551.321.240.911.27
Consolidated Net Income-100.32-13.24-163.56-328.49-370.02-321.69-256.58-235.55
Net Income From Continuing Operations-100.32-13.24-163.56-328.49-370.02-321.69-256.58-235.55
Net Income-100.32-13.24-163.56-328.49-370.02-321.69-256.58-235.55
EPS (Recurring)-0.43-0.38-0.91-1.31-1.40-1.48-1.35-1.38
EPS (Basic, Before Extraordinaries)-0.46-0.06-0.76-1.54-1.75-1.70-1.42-1.32
EPS (Diluted)-0.46-0.06-0.76-1.54-1.75-1.70-1.42-1.32
EBITDA-72.75-95.37-194.59-244.15-257.36-250.13-226.69-242.47
Non-Operating Income (Expense)12.1310.4511.3013.4117.6913.6814.0416.81
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense32.5632.5936.1530.8424.8333.9531.0220.98
Price To Sales Ratio16.4320.3742.9961.3168.2247.8636.2133.98
Gross Margin84.1283.7183.8282.5178.2972.6975.7273.75
Operating Margin-15.60-23.81-65.46-94.64-183.61-236.35-247.61-234.78
Net Margin-19.13-3.11-53.46-124.50-259.95-299.48-276.42-225.53
Shares Outstanding219.32218.28216.52214.26212.58211.11181.90179.38
Market Capitalization26,213.7223,110.1035,247.0637,118.0330,440.1176,466.6755,233.6549,405.85

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments1,430.051,433.83780.451,148.28716.78532.76487.43495.07381.17
Short Term Receivables140.8652.0141.1929.7124.3516.5619.235.510.00
Inventories132.0798.5883.2569.9267.0149.5928.317.030.00
Other Current Assets91.2437.2424.1825.4728.9023.9820.2211.338.28
Total Current Assets1,794.211,621.66929.061,273.38837.04622.89555.19518.95389.44
Net Property, Plant & Equipment139.21115.58104.39102.0895.5297.23113.1122.6412.43
Total Investments and Advances0.000.006.000.0050.040.000.000.000.00
Intangible Assets233.76194.76199.81204.87209.9249.2653.6858.6758.20
Other Assets97.3893.2390.5776.1050.9926.7720.314.301.97
Total Assets2,264.562,025.231,329.841,656.431,243.51796.15742.30604.56462.05
Short Term Debt Incl. Current Port. of LT Debt19.2616.5013.9910.2810.1412.5612.260.000.00
Accounts Payable79.9173.0365.3950.4635.7842.8513.1817.740.00
Other Current Liabilities369.70208.00146.25129.5189.2563.4059.8061.9944.66
Total Current Liabilities468.87297.53225.63190.24135.17118.8185.2479.7344.66
Long Term Debt736.721,297.621,348.391,317.75602.13392.29384.78316.5655.57
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities319.99144.7087.7560.4995.749.1810.610.000.77
Total Liabilities1,525.581,739.851,661.761,568.48833.04520.27480.62396.29100.99
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity738.98285.38-331.9287.95410.47275.88261.67208.27361.06
Total Shareholders Equity738.98285.38-331.9287.95410.47275.88261.67208.27361.06
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity738.98285.38-331.9287.95410.47275.88261.67208.27361.06
Total Liabilities & Stockholders Equity2,264.562,025.231,329.841,656.431,243.51796.15742.30604.56462.05
Book Value Per Share3.451.59-2.240.653.462.682.922.694.71
Tangible Book Value Per Share2.360.51-3.59-0.861.692.212.321.943.95
Full-Time Employees1,6641,271912736613521435373214
Price to Book Ratio36.09102.17-61.28-324.7231.5249.6032.7419.4822.67
Return on Assets-59.53-54.47-50.20-33.21-42.62-38.23-37.77-60.81-55.04
Return on Equity-249.28---193.22-126.66-109.42-108.24-113.92-74.74
Return on Invested Capital-86.52-57.72-73.74-34.26-42.92-44.01-39.34-61.79-46.24
Quick Ratio3.545.123.756.335.704.836.186.428.72
Current Ratio3.835.454.126.696.195.246.516.518.72

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-605.61-1,276.78-913.77-749.57-481.53-434.65-294.09-254.34-324.28
Depreciation26.2716.4511.0110.5822.3126.7720.0810.184.83
Other Funds (Non Cash)107.03405.61222.05241.9652.21103.1657.6156.4845.74
Funds from Operations-472.31-854.72-680.71-497.03-407.01-304.72-216.39-187.68-273.71
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-123.31-80.30-3.18-39.226.58-58.58-2.95-62.9715.74
Cash from Operating Activities-595.62-935.01-683.88-536.25-400.44-363.30-219.35-250.65-257.98
Capital Expenditures-61.95-62.56-21.92-13.29-9.88-7.29-6.24-42.27-14.81
Net Assets From Acquisitions0.000.000.000.000.00-6.700.000.000.00
Sale of Fixed Assets and Businesses0.000.000.003.420.000.000.000.000.00
Purchase or Sale of Investments620.75-2.01-561.25-213.73-24.71-50.290.000.000.00
Purchase of Investments-794.25-2,092.01-1,577.25-588.73-99.71-50.290.000.000.00
Sale Or Maturity of Investments1,415.002,090.001,016.00375.0075.000.000.000.000.00
Other Uses-15.000.000.000.000.000.00-0.580.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities543.80-64.58-583.17-223.60-34.58-64.28-6.82-42.27-14.81
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock117.43959.001,197.37170.87311.66291.92271.94280.778.81
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock117.43959.001,197.37170.87311.66291.92271.94280.778.81
Proceedsfrom Stock Options0.00823.281,084.12152.47292.15269.89245.87261.070.00
Issuance or Reduction of Debt, Net-3.25-4.93143.65-1.22482.22321.700.000.00380.76
Change in Long Term Debt-3.25-4.93143.65-1.22482.22321.700.000.00380.76
Issuance of Long Term Debt0.000.00146.260.00482.22559.280.000.00435.76
Reduction of Long Term Debt-3.25-4.93-2.61-1.220.00-237.580.000.00-55.00
Net Financing Active Other Cash Flow0.000.000.000.00-0.60-1.08-0.944.50-2.83
Other Financing Activities Uses0.000.000.000.00-0.60-1.08-0.940.00-2.83
Cash from Financing Activities114.19954.071,341.02168.44793.27612.55271.00285.28386.74
Exchange Rate Effect-0.560.93-1.31-0.25-1.00-0.930.49-0.00-0.04
Net Change in Cash61.80-44.5972.66-591.66357.25184.0345.33-7.64113.91
Free Cash Flow-657.58-997.58-705.80-549.53-410.32-370.59-225.59-292.92-271.07
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments1,146.631,160.311,223.511,430.051,679.991,856.77
Short Term Receivables259.27215.32178.56140.8665.2655.03
Inventories163.95142.38132.91132.07120.97107.61
Other Current Assets136.66115.9078.1991.2465.6062.18
Total Current Assets1,706.511,633.921,613.171,794.211,931.812,081.58
Net Property, Plant & Equipment139.49134.60131.73139.21116.62117.23
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets274.55229.60231.68233.76220.70192.24
Other Assets105.51104.4499.2897.3891.6188.81
Total Assets2,226.062,102.572,075.862,264.562,360.742,479.86
Short Term Debt Incl. Current Port. of LT Debt30.6317.3714.4319.2612.3210.96
Accounts Payable84.3074.5673.3879.9179.5974.05
Other Current Liabilities481.64346.82273.20369.70325.30226.67
Total Current Liabilities596.58438.74361.01468.87417.21311.68
Long Term Debt719.13729.91734.01736.72732.76732.38
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities184.14176.42275.99319.99265.19186.06
Total Liabilities1,499.841,345.071,371.011,525.581,415.161,230.12
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity726.21757.49704.85738.98945.571,249.73
Total Shareholders Equity726.21757.49704.85738.98945.571,249.73
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity726.21757.49704.85738.98945.571,249.73
Total Liabilities & Stockholders Equity2,226.062,102.572,075.862,264.562,360.742,479.86
Book Value Per Share3.313.473.263.454.455.92
Tangible Book Value Per Share2.062.422.192.363.415.01
Full-Time Employees---1,664--
Price to Book Ratio36.0932.7547.4139.1324.33738.47
Return on Assets-26.41-38.20-61.04-59.53-53.64-48.22
Return on Equity-72.45-87.22-294.46-249.28-165.69-160.54
Return on Invested Capital-6.94-0.89-11.37-22.26-22.05-16.23
Quick Ratio2.593.404.103.544.346.33
Current Ratio2.863.724.473.834.636.68

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-100.32-13.24-163.56-328.49-370.02-321.69
Depreciation9.075.945.695.564.003.75
Other Funds (Non Cash)51.31-56.59-0.66112.97132.37102.83
Funds from Operations-39.93-63.90-158.53-209.95-233.66-215.11
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital3.47-24.93-64.21-37.6413.909.54
Cash from Operating Activities-36.46-88.83-222.74-247.60-219.76-205.57
Capital Expenditures-5.62-6.26-3.48-46.59-2.42-3.48
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments-130.0230.77284.00436.00-759.82231.32
Purchase of Investments-395.02-399.230.000.00-1,184.82-276.68
Sale Or Maturity of Investments265.00430.00284.00436.00425.00508.00
Other Uses0.000.00-15.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-135.6524.51265.52389.41-762.23227.84
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock24.4828.0130.3134.6334.16860.50
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock24.4828.0130.3134.6334.16860.50
Proceedsfrom Stock Options0.000.000.000.00-0.26823.54
Issuance or Reduction of Debt, Net-0.84-0.83-0.80-0.78-0.75-2.70
Change in Long Term Debt-0.84-0.83-0.80-0.78-0.75-2.70
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt-0.84-0.83-0.80-0.78-0.75-2.70
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities23.6427.1829.5133.8633.41857.81
Exchange Rate Effect0.27-0.29-0.550.01-0.981.00
Net Change in Cash-148.20-37.4271.74175.68-949.56881.08
Free Cash Flow-42.09-95.09-226.22-294.19-222.18-209.05

Revenue breakdown

ARIKAYCE2024: 363.71M 2025: 433.77M
BRINSUPRI2025: 172.66M
Non-US2024: 108.91M 2025: 153.47M
United States2024: 254.80M 2025: 452.95M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-306.51%14.1M216.1M2.92M
2026-10-156.26%13.5M215.2M2.60M
2026-09-306.41%13.8M215.2M2.45M
2026-09-155.02%10.8M215.2M3.05M
2026-08-315.32%11.4M215.1M3.40M
2026-08-145.06%10.9M215.1M3.67M
2026-07-315.25%11.4M216.3M3.88M
2026-07-155.41%11.6M214.7M3.79M
2026-06-307.47%16.0M214.7M3.72M
2026-06-158.69%18.6M214.6M3.25M
2026-05-298.91%19.1M214.7M2.87M
2026-05-158.20%17.6M214.7M2.81M
2026-04-306.85%14.7M214.6M2.26M
2026-04-156.48%13.9M213.7M2.42M
2026-03-316.46%13.8M213.1M2.56M
2026-03-134.71%10.0M213.1M2.90M
2026-02-275.29%11.3M213.1M2.92M
2026-02-135.39%11.5M213.1M3.06M
2026-01-305.56%11.7M210.3M3.05M
2026-01-155.65%11.9M210.3M3.00M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call47.5069.7073.800.004.2800.000.000.988-0.0960.006
call50.0067.2071.3056.004.0842.000.000.988-0.0960.006
call55.0062.3066.300.003.6920.000.000.986-0.0960.007
call60.0057.3061.300.003.3350.000.000.985-0.0950.007
call65.0052.3056.300.003.0070.000.000.983-0.0940.008
call70.0047.3051.3041.002.7035.000.000.978-0.1060.010
call75.0042.4046.3030.062.4554.000.000.976-0.1040.011
call80.0037.5040.9033.332.0685.000.000.973-0.1020.012
call85.0032.5035.9028.501.75213.000.000.969-0.1000.013
call87.5030.2033.500.001.7280.000.000.966-0.0980.014
call90.0027.5031.3015.501.6811.000.000.964-0.0970.015
call92.5025.1028.908.101.58811.000.000.961-0.0950.016
call95.0022.9025.7016.001.2843800.000.958-0.0930.017
call97.5020.4023.5020.901.2552,0081.000.931-0.1370.025
call10018.0020.7019.001.0697081.000.924-0.1330.027
call10513.2016.0013.840.9223,8741.000.906-0.1230.031
call1109.0011.7010.200.8184,91518.000.812-0.1860.050
call1155.707.306.360.6591,2412.000.674-0.2300.067
call1203.204.103.660.5916,58816.000.498-0.2620.074
call1251.551.901.600.5335012.000.329-0.2310.067
call1300.551.000.550.56810,9876160.189-0.1680.050
call1350.100.850.200.6855500.000.137-0.1590.041
call1400.000.800.400.8021,7740.000.121-0.1690.038
call1450.002.250.380.9291850.000.103-0.1750.033
call1500.002.200.051.0363920.000.094-0.1830.031
call1550.002.150.011.15179.000.000.087-0.1910.030
call1600.002.150.151.28777.000.000.084-0.2050.029
call1650.002.150.151.3428480.000.077-0.2030.027
call1700.002.150.041.4405320.000.073-0.2080.026
call1750.001.600.051.52842.000.000.069-0.2130.025
call1800.002.151.751.61130.000.000.067-0.2180.024
call1850.002.150.151.68924.000.000.064-0.2220.023
call1900.002.150.101.77037.000.000.062-0.2260.023
call1950.002.150.651.84425.000.000.060-0.2300.022
call2000.002.150.111.91612.000.000.058-0.2330.022
call2100.001.250.532.05113.000.000.055-0.2390.021
call2200.002.150.702.2161.000.000.055-0.2540.021
call2300.002.150.702.3362.000.000.053-0.2590.020
call2400.002.150.402.4153.000.000.049-0.2550.019
put47.500.002.150.002.8810.000.00-0.012-0.0910.006
put50.000.002.150.182.7331.000.00-0.012-0.0900.006
put55.000.002.150.002.4570.000.00-0.014-0.0890.007
put60.000.002.150.052.19717.000.00-0.015-0.0880.007
put65.000.000.250.601.89147.000.00-0.017-0.0790.008
put70.000.001.550.151.81970.000.00-0.022-0.0980.010
put75.000.002.150.101.60158.000.00-0.024-0.0950.011
put80.000.000.900.051.41511,3940.00-0.027-0.0930.012
put85.000.002.150.101.2302361.00-0.031-0.0900.013
put87.500.002.200.251.14166.000.00-0.033-0.0880.014
put90.000.002.200.231.0483,3280.00-0.036-0.0870.015
put92.500.002.250.100.97134.000.00-0.039-0.0850.016
put95.000.100.300.300.8834410.00-0.042-0.0830.017
put97.500.002.301.310.9172070.00-0.069-0.1260.025
put1000.001.300.350.8268760.00-0.076-0.1220.027
put1050.250.550.400.6471,11810.00-0.094-0.1120.031
put1100.651.300.800.63382328.00-0.197-0.1870.052
put1151.852.252.400.55735410.00-0.326-0.2170.067
put1203.805.004.700.6682436.00-0.502-0.2540.074
put1256.509.209.750.7851730.00-0.670-0.2190.068
put13010.3013.3023.000.86370.000.00-0.812-0.1530.050
put13514.9017.8024.300.9029.000.00-0.864-0.1440.041
put14018.9022.7020.301.1010.000.00-0.885-0.1490.036
put14523.9027.700.001.2400.000.00-0.897-0.1590.033
put15028.9032.7023.001.3740.000.00-0.906-0.1670.031
put15533.9037.600.001.4770.000.00-0.913-0.1740.029
put16038.8042.700.001.6170.000.00-0.919-0.1800.028
put16543.8047.700.001.7290.000.00-0.923-0.1860.027
put17048.8052.7054.401.8350.000.00-0.927-0.1900.026
put17553.8057.600.001.9110.000.00-0.931-0.1950.025
put18058.8062.6049.012.0080.000.00-0.933-0.1990.024
put18563.8067.700.002.1270.000.00-0.936-0.2020.023
put19068.8072.7060.602.2160.000.00-0.938-0.2060.023
put19573.8077.600.002.2720.000.00-0.940-0.2090.022
put20078.8082.700.002.3850.000.00-0.942-0.2120.022
put21088.8092.600.002.5130.000.00-0.945-0.2170.021
put22098.80102.789.102.6890.000.00-0.947-0.2220.020
put230108.8112.70.002.8280.000.00-0.949-0.2260.019
put240118.8122.60.002.9280.000.00-0.951-0.2290.019

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-033Initial statement of beneficial ownership of securities2026-10-30SEC
2026-11-03144Filing for proposed sale of securities under Rule 144.SEC
2026-10-298-KCurrent report2026-10-29SEC
2026-10-2910-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-204Statement of changes in beneficial ownership of securities2026-10-19SEC
2026-10-203Initial statement of beneficial ownership of securities2026-10-19SEC
2026-10-204Statement of changes in beneficial ownership of securities2026-10-19SEC
2026-10-203Initial statement of beneficial ownership of securities2026-10-19SEC
2026-10-208-KCurrent report2026-10-16SEC
2026-10-058-KCurrent report2026-10-05SEC
2026-09-114Statement of changes in beneficial ownership of securities2026-09-09SEC
2026-09-10144Filing for proposed sale of securities under Rule 144.SEC
2026-08-194Statement of changes in beneficial ownership of securities2026-08-17SEC
2026-08-17144Filing for proposed sale of securities under Rule 144.SEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-10144Filing for proposed sale of securities under Rule 144.SEC
2026-08-074Statement of changes in beneficial ownership of securities2026-08-06SEC
2026-08-06144Filing for proposed sale of securities under Rule 144.SEC
2026-08-068-KCurrent report2026-08-06SEC
2026-08-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-06SCHEDULE 13G/ASEC
2026-07-244Statement of changes in beneficial ownership of securities2026-07-23SEC
2026-07-23144Filing for proposed sale of securities under Rule 144.SEC
2026-07-22SCHEDULE 13G/ASEC
2026-07-168-KCurrent report2026-07-16SEC
2026-07-104Statement of changes in beneficial ownership of securities2026-07-09SEC
2026-07-09144Filing for proposed sale of securities under Rule 144.SEC
2026-07-084Statement of changes in beneficial ownership of securities2026-07-06SEC
2026-07-06144Filing for proposed sale of securities under Rule 144.SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-09003.10M1
2026-080036.10M3
2026-07003.74M3
2026-06004.94M9
2026-050011.94M10
2026-040017.78M3
2026-03006.06M3
2026-02009.76M10
2026-010029.37M20
2025-12009.93M4
2025-110034.40M6

Institutional holders

Manager% owned
BlackRock, Inc.7.29%
FMR LLC7.11%
JPMORGAN CHASE & CO4.81%
VANGUARD PORTFOLIO MANAGEMENT LLC4.80%
VANGUARD CAPITAL MANAGEMENT LLC4.52%
BAKER BROS. ADVISORS LP4.06%
Capital International Investors3.80%
Darwin Global Management, Ltd.2.97%
AMERIPRISE FINANCIAL INC2.85%
Orbis Allan Gray Ltd2.80%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND3.18%
Growth Fund of America3.09%
JPMorgan Large Cap Growth Fund1.29%
VANGUARD SMALL-CAP INDEX FUND1.15%
VANGUARD EXTENDED MARKET INDEX FUND1.15%
VANGUARD MID-CAP INDEX FUND1.08%
VANGUARD GROWTH INDEX FUND0.83%
Fidelity Advisor Growth Opportunities Fund0.76%
iShares Biotechnology ETF0.70%
JPMorgan Mid Cap Growth Fund0.66%

OakChart. INSM. Cached 15 minutes.